Literature DB >> 18199592

Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice.

Nicole Stupka1, Jonathan D Schertzer, Rhonda Bassel-Duby, Eric N Olson, Gordon S Lynch.   

Abstract

Calcineurin activation ameliorates the dystrophic pathology of hindlimb muscles in mdx mice and decreases their susceptibility to contraction damage. In mdx mice, the diaphragm is more severely affected than hindlimb muscles and more representative of Duchenne muscular dystrophy. The constitutively active calcineurin Aalpha transgene (CnAalpha) was overexpressed in skeletal muscles of mdx (mdx CnAalpha*) mice to test whether muscle morphology and function would be improved. Contractile function of diaphragm strips and extensor digitorum longus and soleus muscles from adult mdx CnAalpha* and mdx mice was examined in vitro. Hindlimb muscles from mdx CnAalpha* mice had a prolonged twitch time course and were more resistant to fatigue. Because of a slower phenotype and a decrease in fiber cross-sectional area, normalized force was lower in fast- and slow-twitch muscles of mdx CnAalpha* than mdx mice. In the diaphragm, despite a slower phenotype and a approximately 35% reduction in fiber size, normalized force was preserved. This was likely mediated by the reduction in the area of the diaphragm undergoing degeneration (i.e., mononuclear cell and connective and adipose tissue infiltration). The proportion of centrally nucleated fibers was reduced in mdx CnAalpha* compared with mdx mice, indicative of improved myofiber viability. In hindlimb muscles of mdx mice, calcineurin activation increased expression of markers of regeneration, particularly developmental myosin heavy chain isoform and myocyte enhancer factor 2A. Thus activation of the calcineurin signal transduction pathway has potential to ameliorate the mdx pathophysiology, especially in the diaphragm, through its effects on muscle degeneration and regeneration and endurance capacity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199592     DOI: 10.1152/ajpregu.00375.2007

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  16 in total

1.  Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology.

Authors:  Val A Fajardo; Paige J Chambers; Emma S Juracic; Bradley A Rietze; Daniel Gamu; Catherine Bellissimo; Frenk Kwon; Joe Quadrilatero; A Russell Tupling
Journal:  Hum Mol Genet       Date:  2018-12-01       Impact factor: 6.150

2.  Myospryn is a calcineurin-interacting protein that negatively modulates slow-fiber-type transformation and skeletal muscle regeneration.

Authors:  Ondra M Kielbasa; Joseph G Reynolds; Chia-Ling Wu; Christine M Snyder; Min Y Cho; Hartmut Weiler; Susan Kandarian; Francisco J Naya
Journal:  FASEB J       Date:  2011-03-22       Impact factor: 5.191

3.  SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.

Authors:  Davi A G Mázala; Stephen J P Pratt; Dapeng Chen; Jeffery D Molkentin; Richard M Lovering; Eva R Chin
Journal:  Am J Physiol Cell Physiol       Date:  2015-02-04       Impact factor: 4.249

Review 4.  The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle.

Authors:  Kunihiro Sakuma; Akihiko Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-04-01

Review 5.  Therapeutic targeting of signaling pathways in muscular dystrophy.

Authors:  Shephali Bhatnagar; Ashok Kumar
Journal:  J Mol Med (Berl)       Date:  2009-10-09       Impact factor: 4.599

Review 6.  Wasting mechanisms in muscular dystrophy.

Authors:  Jonghyun Shin; Marjan M Tajrishi; Yuji Ogura; Ashok Kumar
Journal:  Int J Biochem Cell Biol       Date:  2013-05-11       Impact factor: 5.085

7.  Calcineurin A versus NS5A-TP2/HD domain containing 2: a case study of site-directed low-frequency random mutagenesis for dissecting target specificity of peptide aptamers.

Authors:  Silvia Dibenedetto; David Cluet; Pierre-Nicolas Stebe; Véronique Baumle; Jérémie Léault; Raphaël Terreux; Marc Bickle; Benoit D E Chassey; Ivan Mikaelian; Pierre Colas; Martin Spichty; Michele Zoli; Brian B Rudkin
Journal:  Mol Cell Proteomics       Date:  2013-04-10       Impact factor: 5.911

8.  G-CSF does not influence C2C12 myogenesis despite receptor expression in healthy and dystrophic skeletal muscle.

Authors:  Craig R Wright; Erin L Brown; Paul A Della-Gatta; Alister C Ward; Gordon S Lynch; Aaron P Russell
Journal:  Front Physiol       Date:  2014-05-01       Impact factor: 4.566

9.  Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles.

Authors:  Natasha McRae; Leonard Forgan; Bryony McNeill; Alex Addinsall; Daniel McCulloch; Chris Van der Poel; Nicole Stupka
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

10.  Grafting of a single donor myofibre promotes hypertrophy in dystrophic mouse muscle.

Authors:  Luisa Boldrin; Jennifer E Morgan
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.